Publications

(2022). Local Ancestry‐Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations. Clinical Pharmacology and Therapeutics.

DOI

(2022). Bringing pharmacomicrobiomics to the clinic through well-designed studies. Clinical and Translational Science.

DOI

(2022). ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. Blood.

DOI

(2021). Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans. Frontiers in Pharmacology.

DOI

(2021). Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum: A Nonblinded, Randomized Controlled Trial. Clinical and Translational Science.

DOI

(2021). Racial, Ethnic, and Gender Differences in Obesity and Body Fat Distribution: An All of Us Research Program Demonstration Project. PLoS One.

DOI

(2021). Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos. Clinical and Translational Science.

DOI

(2021). Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches. Frontiers in Pharmacology.

DOI

(2020). Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine.

DOI

(2018). Psychological and Genetic Predictors of Pain Tolerance. American Society for Clinical Pharmacology and Therapeutics.

DOI

(2017). Influence of HLA alleles and KIR types on Heparin-Induced Thrombocytopenia. Pharmacotherapy.

DOI

(2017). Warfarin Pharmacogenomics in Diverse Populations. Pharmacotherapy.

DOI

(2017). Comparison of HLA Allelic Imputation Programs. PLoS One.

DOI